arrow
S

Silvy Lachance

hopital maisonneuve-rosemont
H指数:22
被引数:1,977

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Risk factors for EBV reactivation and impact of graft composition following GVHD prophylaxis with rabbit ATG or PTCy

兔ATG或PTCy作为GVHD预防措施后,EBV再激活的风险因素及移植物组成的影响

2026-06-090
PRE
Real-world Canadian data on belumosudil therapy in heavily pretreated patients with steroid-refractory chronic graft-versus-host disease: treatment outcomes and risk factor analysis for failure-free survival

真实世界中,关于重度预治疗且对糖皮质激素难治的慢性移植物抗宿主病患者接受belumosudil治疗的加拿大数据:治疗结局及无失败生存期的风险因素分析

2025-10-250
OA
Comparison of Outcomes after UM171-Expanded Cord Blood and Six Conventional Donor Source Transplants: A Matched Analysis from the EBMT Registry

UM171扩增脐带血与六种常规供者来源移植后结局的比较:EBMT登记处的一项匹配分析

2025-08-140
PRE
Management of liver sinusoidal obstruction syndrome/veno-occlusive disease in adults: a 2025 perspective from an international expert group

成人肝窦阻塞综合征/静脉闭塞性疾病的管理:国际专家小组的2025年展望

2025-04-220
PRE
A Pilot Study of UM171-Expanded Cord Blood Grafts for Tandem Auto/Allogeneic Hematopoietic Cell Transplant in High and Ultra-High-Risk Myeloma Patients
2025-01-010
OAAI
Impact of Implementing a Bendamustine-Based Conditioning Regimen on Outcomes of Autologous Stem Cell Transplantation in Lymphoma while Novel Cellular Therapies Emerge
2023-01-015
OAAI
UM171-Expanded Cord Blood Transplants Support Robust T Cell Reconstitution with Low Rates of Severe Infections
2021-01-0110
OAAI
Hematopoietic stem cell transplantation using single UM171-expanded cord blood: a single-arm, phase 1-2 safety and feasibility study
2020-02-01160
PREAI
A Phase 2, Randomized, Double-blind, Placebo-Controlled Trial of Presatovir for the Treatment of Respiratory Syncytial Virus Upper Respiratory Tract Infection in Hematopoietic-Cell Transplant Recipients
2019-12-0354
OAAI
The influence of gut-decontamination prophylactic antibiotics on acute graft-versus-host disease and survival following allogeneic hematopoietic stem cell transplantation

肠道去污预防性抗生素对异基因造血干细胞移植后急性移植物抗宿主病和生存率的影响

2016-12-2756
OAAI
PHASE II CLINICAL TRIAL OF ALLODEPLETED T CELL IMMUNOTHERAPY (ATIR101) POST-TRANSPLANT RESULTS IN DECREASED TRANSPLANT-RELATED MORTALITY AND IMPROVED SURVIVAL IN ACUTE LEUKEMIA PATIENTS UNDERGOING T-DEPLETED HAPLOIDENTICAL STEM CELL TRANSPLANTATION
2016-06-010
PREAI